Detalles de la búsqueda
1.
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
Expert Opin Biol Ther
; 24(4): 305-312, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38664937
2.
Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial.
BioDrugs
; 37(3): 433-440, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36881323
Resultados
1 -
2
de 2
1
Próxima >
>>